| |
Records |
Links |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction; European Commission |
|
| |
Title |
The European Union and the drug phenomenon : frequently asked questions |
Type |
Book Whole |
| |
Year |
2010 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
12 |
|
| |
Keywords |
addiction; AOD use, abuse, and dependence; chemical addiction; public health; public policy on AOD; illicit drug; coordination of activities; law enforcement; Europe; international area |
|
| |
Abstract |
Respect for fundamental rights, protection of public health, well-being, social cohesion and security are the objectives that guide the actions taken by the European Union in the field of illicit drugs. The EU drugs strategy 2005–12 provides the framework for enhanced coordination between action taken at national, EU and international level and commits the members of the EU to tackle illicit drugs by striking a balance between reducing supply and demand. This joint publication between the EMCDDA and the European Commission brings together some of the key frequently asked questions on the EU’s drugs policy and how it functions. Further details can be found via the websites and other links provided at the end of each answer. The brochure exists in English and French language versions. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Brochures |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN  |
1831-4929 |
ISBN |
978-92-9168-449-6 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
Aussi disponible en français: 50-11531 |
Approved |
no |
|
| |
Call Number |
50-11530 |
Serial |
49780 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Observatoire européen des drogues et des toxicomanies; Commission européenne (eds) |
|
| |
Title |
L'Union européenne et le phénomène des drogues : questions fréquemment posées |
Type |
Book Whole |
| |
Year |
2010 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
12 |
|
| |
Keywords |
addiction; AOD use, abuse, and dependence; chemical addiction; public health; public policy on AOD; illicit drug; coordination of activities; law enforcement; Europe; international area |
|
| |
Abstract |
Respect for fundamental rights, protection of public health, well-being, social cohesion and security are the objectives that guide the actions taken by the European Union in the field of illicit drugs. The EU drugs strategy 2005–12 provides the framework for enhanced coordination between action taken at national, EU and international level and commits the members of the EU to tackle illicit drugs by striking a balance between reducing supply and demand. This joint publication between the EMCDDA and the European Commission brings together some of the key frequently asked questions on the EU’s drugs policy and how it functions. Further details can be found via the websites and other links provided at the end of each answer. The brochure exists in English and French language versions. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office des publications de l'Union européenne |
Place of Publication |
Luxembourg |
Editor |
Observatoire européen des drogues et des toxicomanies; Commission européenne |
|
| |
Language |
French |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Brochures |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1831-4929 |
ISBN |
978-92-9168-448-9 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
Also available in English: 50-11530 |
Approved |
no |
|
| |
Call Number |
50-11531 |
Serial |
49781 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Work programme 2011 |
Type |
Book Whole |
| |
Year |
2011 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
76 |
|
| |
Keywords |
government and politics; monitoring; AOD use, abuse, and dependence; international area; Europe |
|
| |
Abstract |
The 2011 work programme takes forward activities begun in 2010 to implement the EMCDDA’s three-year strategy (2010–12). Key themes of this strategy are the consolidation of core data, investment in more complex and policy-relevant analysis, and the development of a small number of new areas of strategic importance. Progress was made in all these areas in 2010, and this document details the next steps to be taken. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Work programmes and strategies |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1831-4090 |
ISBN |
978-92-9168-458-8 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-11747 |
Serial |
50012 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Work programme 2010 |
Type |
Book Whole |
| |
Year |
2010 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
70 |
|
| |
Keywords |
government and politics; monitoring; AOD use, abuse, and dependence; international area; Europe |
|
| |
Abstract |
The 2010 work programme is the first to fall under the EMCDDA’s new three-year strategy and work programme (2010–12). In terms of substantive technical activities, the three-year strategy aims to consolidate the core data sets held by the agency and enable more complex analysis of them. It also scales up and develops some new areas of strategic importance. This means that 2010 will necessarily be a formative and exploratory year during which the structures and approaches needed to deliver the objectives set out in the work programme are put in place. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Work programmes and strategies |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1831-4090 |
ISBN |
978-92-9168-418-2 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-15004 |
Serial |
50023 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Cost and financing of drug treatment services in Europe : an exploratory study |
Type |
Report |
| |
Year |
2011 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
23 |
|
| |
Keywords |
Aod; AOD use, abuse, and dependence; addiction; heroin; treatment and maintenance; detoxification; inpatient care; outpatient care; methadone; heroin-assisted treatment; financial management; treatment cost; treatment method; financial statement; financing; study; Europe; report |
|
| |
Abstract |
Recent estimates suggest that, each year, over 1 million Europeans receive treatment for problems related to the use of illicit drugs (EMCDDA, 2010). Of these, more than half receive opioid substitution treatment for problems related to opioid drugs, primarily heroin. The current levels of provision of drug treatment services in the European Union are the result of an expansion of services that has taken place during the last two decades. For much of that time, services expanded against a background of a growing drug problem, and one in which economic conditions were largely favourable. Now, however, in an era of cuts in government expenditure, managing the costs of treatment and ensuring the highest quality and best outcomes for the lowest possible cost are priorities. While measuring and improving drug treatment outcomes have been relatively high on the research agenda in recent years, the cost of treatment has received far less research attention. Addressing this information gap is likely to have a number of benefi ts for both decision-makers and treatment providers. On the one hand, service providers need accurate information on the costs of service provision in order to plan the allocation of resources. On the other, decision-makers and funders can use such information as a means of cost control, for example, by comparing costs of similar services or those of alternative providers of similar services. Finally, as a part of a fuller economic analysis, information on service costs is needed to determine the cost-effectiveness of interventions and treatment programmes. The cost of drug treatment in Europe is looked at from two main angles in this Selected issue. First, it presents an overview of the main sources of drug treatment funding and the financing mechanisms that are employed in European countries. The available data are presented on who is paying for drug treatment, how funding is organised, and how funding is distributed among different treatment modalities. This is followed by an analysis of the unit costs of different types of drug treatment. Costs related to opioid substitution treatment including the costs of substitution medication for a number of European countries are presented here. This publication keeps a tight focus on the cost of drug treatment and does not attempt to undertake a broader economic analysis of the healthcare and social costs relating to illicit drugs. This Selected issue represents a fi rst attempt to provide a European overview of drug treatment costs, and individual countries are brought into focus to illustrate specifi c aspects of the analysis. This subject is both topical and methodologically challenging. The varying availability of information as well as the complexity of funding arrangements mean that, at best, only very incomplete estimates can be made of the costs of (or expenditure on) drug treatment in Europe. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Selected issues |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1830-7957 |
ISBN |
978-92-9168-464-9 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-12180 |
Serial |
50911 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Trends in injecting drug use in Europe |
Type |
Report |
| |
Year |
2010 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
22 |
|
| |
Keywords |
intravenous injection; addiction; AOD dependence; chemical addiction; treatment and maintenance; patient; prevalence; risk-taking behavior; AOD effects and consequences; target group; intravenous drug user; drug substitution therapy; harm reduction; needle distribution and exchange; intervention (persuasion to treatment); route of administration by method or body site; history; Europe |
|
| |
Abstract |
Trends in injecting drug use in Europe is the title of the latest EMCDDA Selected issue publication. This volume brings together data from a wide variety of sources as it describes Europe’s current drug injecting problem and plots its trends in recent years. Responses to drug injecting and measures to reduce the harm caused by this form of drug use are also reviewed. The report finds that the available data point to a stable or declining trend of injecting in most European countries, with effective treatment and harm-reduction measures now reaching many users. Despite this, there is still a large population of drug injectors in Europe, and there continue to be signs of recent recruitment in some countries. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Selected issues |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1830-7957 |
ISBN |
978-92-9168-412-0 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
Summary of study also available: 50-11356 |
Approved |
no |
|
| |
Call Number |
50-11352 |
Serial |
51148 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Hüsler, Gebhard; Plancherel, Bernard |
|
| |
Title |
Social integration of adolescents at risk : results from a cohort study |
Type |
Journal Article |
| |
Year |
2007 |
Publication |
Vulnerable Children and Youth Studies |
Abbreviated Journal |
|
|
| |
Volume |
2 |
Issue |
3; 12/2007 |
Pages |
215-226 |
|
| |
Keywords |
target group; adolescent; high-risk youth; social integration; school; work; family; criminality; juvenile delinquency; AOD use; alcohol; tobacco product; illicit drug; cannabis; Switzerland |
|
| |
Abstract |
Using a sample of 614 youths, this study examined differences and similarities between adolescents at risk (age range 11-20 years), and their integration in school or vocational training. We found that mood states (depression, anxiety), secure self (self-esteem and self-efficacy), relationship with parents, delinquency and substance use (alcohol, tobacco and cannabis) were variables which largely influenced social integration (school, work) for youths with poor sociodemographic backgrounds. An important variable we introduced here was sociodemographic background, which investigated the social situation of a youth. We distinguished two different groups (good vs. poor sociodemographic background). There were important differences between both groups. Youths with a poor sociodemographic background scored higher in suicidality and health complaints. The most striking differences were in substance use and delinquency. The structural equation model showed that poor mood was related to substance use at the start. Important paths were found in mood states over time, as for substance use, but interactions between both variables were small. We ran different models (poor vs. good social background, Swiss vs. migrant youths), and concluded that secure self and good family relations protected against poor mood and substance use and both variables indirectly influenced integration 2-3 years later. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
|
Place of Publication |
|
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1745-0128 (Print); 1745-0136 (Online) |
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-11662 |
Serial |
59923 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Sedefov, Roumen; Gallegos, Ana; King, Les; Lopez, Dominique; Auwärter, Volker; Hughes, Brendan; Griffiths, Paul |
|
| |
Title |
Understanding the “Spice” phenomenon |
Type |
Book Whole |
| |
Year |
2009 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
34 |
|
| |
Keywords |
addiction; AOD dependence; chemical addiction; spice; internet; Europe |
|
| |
Abstract |
Smokable herbal mixtures under the brand name ‘Spice’ are known to have been sold on the Internet and in various specialised shops since at least 2006 and anecdotal reports suggest that those products may have been available as early as 2004. Although advertised as an ‘exotic incense blend which releases a rich aroma’ and ‘not for human consumption’, when smoked, Spice products have been reported by some users to have effects similar to those of cannabis. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxembourg |
Editor |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-5767 |
ISBN |
978-92-9168-411-3 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-10754 |
Serial |
49703 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Responding to drug use and related problems in recreational settings |
Type |
Book Whole |
| |
Year |
2012 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
11 |
|
| |
Keywords |
AOD use; AOD associated consequences; public AOD use; policy recommendations; prevalence; Europe |
|
| |
Abstract |
Throughout the year, bars, nightclubs, discotheques and other recreational venues provide young Europeans with opportunities to socialise and dance, often offering entertainment such as concerts and dance parties. In addition, large music festivals that are organised mostly during the summer months attract thousands of visitors. Surveys show that in many recreational venues the use of drugs is more prevalent than in the general population (EMCDDA, 2006). |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) |
Place of Publication |
Lisbon |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Thematic papers |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-5767 |
ISBN |
978-92-9168-556-1 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-12424 |
Serial |
49889 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Burkhart, Gregor; Fegert, Jörg M.; Schepker, Renate; Keller, Ferdinand; Ludolph, Andrea G.; Plener, Paul L.; Williamson, Anette E.; Volmer-Berthele, Nora; Weninger, Laura E.; Kapusta, Nestor D.; 't Hart-Kerkhoffs, Lisette |
|
| |
Title |
Preventing later substance use disorders in at-risk children and adolescents : a review of the theory and evidence base of indicated prevention |
Type |
Report |
| |
Year |
2009 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
84 |
|
| |
Keywords |
indicated prevention; AODD and AODR disorder; child; adolescent; childhood; risk factors; AOD use, abuse, and dependence |
|
| |
Abstract |
This review on indicated prevention adds to the current knowledge and understanding of risk factors in the development of later drug problems and dependence, focusing on the mental health and behavioural problems that develop during childhood. Indicated prevention is a relatively new branch of drug prevention and can be seen as the third part of the ’prevention chain’, after universal and selective prevention. Its aim is not necessarily to prevent drug use or initiation to it, but rather to prevent the development of dependence, diminish frequency of use and avert ’dangerous’ patterns of substance use (e.g. moderate instead of binge-drinking). |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Lisbon; Luxembourg |
Editor |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-5767 |
ISBN |
987-92-9168-349-9 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-10121 |
Serial |
50662 |
|
| Permanent link to this record |
